Last updated on May 2018

Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Hemodialysis | Cardiovascular Disease | Vitamin K Deficiency | Chronic Kidney Disease Stage 3 | Chronic Kidney Disease Stage 4 | Chronic Kidney Disease Stage 5
  • Age: Between 18 - 65 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Chronic Kidney Disease Stages 3 to 5
  • Receiving hemodialysis treatment for at least 3 months
  • Subject understands the study protocol and agrees to comply with it
  • Informed consent documents signed by subject

Exclusion Criteria:

  • Using vitamin supplements containing vitamin K
  • History of metabolic gastrointestinal diseases
  • Subjects presenting chronic degenerative and/or inflammatory diseases
  • Receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters (salicylates, antibiotics)
  • Subjects receiving corticosteroid
  • Use of anticoagulants
  • History of soy allergy
  • Have an unstable medical condition, such as having a life expectancy of less than 6 months in the judgment of the investigator
  • Known sensitivity, intolerance, or other adverse response to study drugs which would prevent compliance with study medication
  • Subjects who have participated in a clinical study more recently than one month before the current study

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.